Sparks Janet D, Sparks Charles E
Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.
J Clin Invest. 2008 Jun;118(6):2012-5. doi: 10.1172/JCI35693.
Excessive production of triglyceride-rich VLDL, which can result from dietary overindulgence, underlies metabolic syndrome--a combination of disorders including high blood pressure, obesity, high triglyceride, and insulin resistance--and places individuals at increased risk of developing cardiovascular disease and type 2 diabetes. However, the link between VLDL overproduction and insulin resistance has remained unclear. VLDL assembly in the liver is catalyzed by microsomal triglyceride transfer protein (MTP). In this issue of the JCI, Kamagate et al. investigate the events controlling hepatic MTP expression and VLDL production and secretion (see the related article beginning on page 2347). They demonstrate that MTP is a target of the transcription factor FoxO1 and that excessive VLDL production associated with insulin resistance is caused by the inability of insulin to regulate FoxO1 transcriptional activation of MTP.
富含甘油三酯的极低密度脂蛋白(VLDL)产生过多,这可能源于饮食过度放纵,是代谢综合征的基础——代谢综合征是包括高血压、肥胖、高甘油三酯和胰岛素抵抗在内的多种疾病的组合——并使个体患心血管疾病和2型糖尿病的风险增加。然而,VLDL产生过多与胰岛素抵抗之间的联系仍不清楚。肝脏中VLDL的组装由微粒体甘油三酯转移蛋白(MTP)催化。在本期《临床研究杂志》中,卡马盖特等人研究了控制肝脏MTP表达以及VLDL产生和分泌的相关事件(见第2347页开始的相关文章)。他们证明MTP是转录因子FoxO1的一个靶点,并且与胰岛素抵抗相关的VLDL产生过多是由于胰岛素无法调节FoxO1对MTP的转录激活所致。